← Back to patent-cliff list
Tribendimidine
Tier C — Watch / tradeTribendimidine
-
Originator
2004
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Nicotinic receptors
Indications (approved)：钩虫感染, 蛔虫病
Regional status
US
-
EU
-
China
Approved
2004-04-30
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Tribendimidine?
Approved indications include: 钩虫感染, 蛔虫病.
When does the Tribendimidine patent expire?
No public expiry year is available for Tribendimidine yet; this page updates once verified.
How do I get a quote for Tribendimidine intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-27